Arthur Bedrosian, CEO, Lannett Company Inc 00:00:00
Lannett Company CEO Arthur Bedrosian on business in the generic market and the $1.23 billion acquisition of Kremers Urban Pharmaceuticals.
Lannett Company CEO Arthur Bedrosian on business in the generic market and the $1.23 billion acquisition of Kremers Urban Pharmaceuticals.